Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
biopsy  ||| S:10 E:17 ||| JJ
length  ||| S:17 E:24 ||| NN
on  ||| S:24 E:27 ||| IN
the  ||| S:27 E:31 ||| DT
rate  ||| S:31 E:36 ||| NN
of  ||| S:36 E:39 ||| IN
positive  ||| S:39 E:48 ||| JJ
temporal  ||| S:48 E:57 ||| JJ
artery  ||| S:57 E:64 ||| NN
biopsies  ||| S:64 E:73 ||| NNS
To  ||| S:73 E:76 ||| TO
investigate  ||| S:76 E:88 ||| VB
the  ||| S:88 E:92 ||| DT
relationship  ||| S:92 E:105 ||| NN
between  ||| S:105 E:113 ||| IN
temporal  ||| S:113 E:122 ||| JJ
artery  ||| S:122 E:129 ||| NN
biopsy  ||| S:129 E:136 ||| NNS
( ||| S:136 E:137 ||| -LRB-
TAB ||| S:137 E:140 ||| NNP
)  ||| S:140 E:142 ||| -RRB-
length  ||| S:142 E:149 ||| NN
and  ||| S:149 E:153 ||| CC
the  ||| S:153 E:157 ||| DT
diagnostic  ||| S:157 E:168 ||| JJ
sensitivity  ||| S:168 E:180 ||| NN
for  ||| S:180 E:184 ||| IN
giant  ||| S:184 E:190 ||| JJ
cell  ||| S:190 E:195 ||| NN
arteritis  ||| S:195 E:205 ||| NNS
( ||| S:205 E:206 ||| -LRB-
GCA ||| S:206 E:209 ||| NNP
) ||| S:209 E:210 ||| -RRB-
.  ||| S:210 E:212 ||| .
TAB  ||| S:212 E:216 ||| NN
pathology  ||| S:216 E:226 ||| NN
reports  ||| S:226 E:234 ||| NNS
were  ||| S:234 E:239 ||| VBD
reviewed  ||| S:239 E:248 ||| VBN
for  ||| S:248 E:252 ||| IN
histological  ||| S:252 E:265 ||| JJ
findings  ||| S:265 E:274 ||| NNS
and  ||| S:274 E:278 ||| CC
formalin-fixed  ||| S:278 E:293 ||| NNP
TAB  ||| S:293 E:297 ||| NNP
lengths ||| S:297 E:304 ||| NNS
.  ||| S:304 E:306 ||| .
The  ||| S:306 E:310 ||| DT
patient ||| S:310 E:317 ||| NN
's  ||| S:317 E:320 ||| POS
charts  ||| S:320 E:327 ||| NNS
were  ||| S:327 E:332 ||| VBD
reviewed  ||| S:332 E:341 ||| VBN
for  ||| S:341 E:345 ||| IN
clinical  ||| S:345 E:354 ||| JJ
data ||| S:354 E:358 ||| NNS
.  ||| S:358 E:360 ||| .
TAB  ||| S:360 E:364 ||| NN
was  ||| S:364 E:368 ||| VBD
considered  ||| S:368 E:379 ||| VBN
positive  ||| S:379 E:388 ||| JJ
if  ||| S:388 E:391 ||| IN
there  ||| S:391 E:397 ||| EX
was  ||| S:397 E:401 ||| VBD
a  ||| S:401 E:403 ||| DT
mononuclear  ||| S:403 E:415 ||| JJ
cell  ||| S:415 E:420 ||| NN
infiltrate  ||| S:420 E:431 ||| NN
in  ||| S:431 E:434 ||| IN
the  ||| S:434 E:438 ||| DT
vessel  ||| S:438 E:445 ||| NN
wall ||| S:445 E:449 ||| NN
.  ||| S:449 E:451 ||| .
Biopsy-negative  ||| S:451 E:467 ||| NNP
GCA  ||| S:467 E:471 ||| NNP
was  ||| S:471 E:475 ||| VBD
diagnosed  ||| S:475 E:485 ||| VBN
when  ||| S:485 E:490 ||| WRB
patients  ||| S:490 E:499 ||| NNS
fulfilled  ||| S:499 E:509 ||| VBD
the  ||| S:509 E:513 ||| DT
American  ||| S:513 E:522 ||| NNP
College  ||| S:522 E:530 ||| NNP
of  ||| S:530 E:533 ||| IN
Rheumatology  ||| S:533 E:546 ||| NNP
classification  ||| S:546 E:561 ||| NN
criteria ||| S:561 E:569 ||| NNS
,  ||| S:569 E:571 ||| ,
in  ||| S:571 E:574 ||| IN
addition  ||| S:574 E:583 ||| NN
to  ||| S:583 E:586 ||| TO
favorable  ||| S:586 E:596 ||| JJ
rapid  ||| S:596 E:602 ||| JJ
response  ||| S:602 E:611 ||| NN
to  ||| S:611 E:614 ||| TO
steroid  ||| S:614 E:622 ||| VB
therapy ||| S:622 E:629 ||| NN
.  ||| S:629 E:631 ||| .
Patients  ||| S:631 E:640 ||| NNS
were  ||| S:640 E:645 ||| VBD
divided  ||| S:645 E:653 ||| VBN
into  ||| S:653 E:658 ||| IN
3  ||| S:658 E:660 ||| CD
groups  ||| S:660 E:667 ||| NNS
according  ||| S:667 E:677 ||| VBG
to  ||| S:677 E:680 ||| TO
the  ||| S:680 E:684 ||| DT
clinical  ||| S:684 E:693 ||| JJ
and  ||| S:693 E:697 ||| CC
histological  ||| S:697 E:710 ||| JJ
features ||| S:710 E:718 ||| NNS
:  ||| S:718 E:720 ||| :
Biopsy-positive  ||| S:720 E:736 ||| NNP
GCA ||| S:736 E:739 ||| NNP
,  ||| S:739 E:741 ||| ,
biopsy-negative  ||| S:741 E:757 ||| NNP
GCA ||| S:757 E:760 ||| NNP
,  ||| S:760 E:762 ||| ,
and  ||| S:762 E:766 ||| CC
no  ||| S:766 E:769 ||| DT
GCA.  ||| S:769 E:774 ||| CD
305  ||| S:774 E:778 ||| CD
TAB  ||| S:778 E:782 ||| NN
reports  ||| S:782 E:790 ||| NNS
of  ||| S:790 E:793 ||| IN
173  ||| S:793 E:797 ||| CD
individuals  ||| S:797 E:809 ||| NNS
were  ||| S:809 E:814 ||| VBD
reviewed ||| S:814 E:822 ||| VBN
.  ||| S:822 E:824 ||| .
When  ||| S:824 E:829 ||| WRB
only  ||| S:829 E:834 ||| RB
GCA  ||| S:834 E:838 ||| JJ
patients  ||| S:838 E:847 ||| NNS
TAB-positive  ||| S:847 E:860 ||| JJ
and  ||| S:860 E:864 ||| CC
TAB-negative  ||| S:864 E:877 ||| NNP
were  ||| S:877 E:882 ||| VBD
considered ||| S:882 E:892 ||| VBN
,  ||| S:892 E:894 ||| ,
TAB  ||| S:894 E:898 ||| NNP
in  ||| S:898 E:901 ||| IN
the  ||| S:901 E:905 ||| DT
biopsy-positive  ||| S:905 E:921 ||| JJ
patients  ||| S:921 E:930 ||| NNS
was  ||| S:930 E:934 ||| VBD
significantly  ||| S:934 E:948 ||| RB
longer  ||| S:948 E:955 ||| RBR
than  ||| S:955 E:960 ||| IN
in  ||| S:960 E:963 ||| IN
biopsy-negative  ||| S:963 E:979 ||| JJ
cases  ||| S:979 E:985 ||| NNS
( ||| S:985 E:986 ||| -LRB-
p=0.008 ||| S:986 E:993 ||| NNP
) ||| S:993 E:994 ||| -RRB-
.  ||| S:994 E:996 ||| .
The  ||| S:996 E:1000 ||| DT
rate  ||| S:1000 E:1005 ||| NN
of  ||| S:1005 E:1008 ||| IN
positive  ||| S:1008 E:1017 ||| JJ
biopsies  ||| S:1017 E:1026 ||| NNS
was  ||| S:1026 E:1030 ||| VBD
only  ||| S:1030 E:1035 ||| RB
19 ||| S:1035 E:1037 ||| CD
%  ||| S:1037 E:1039 ||| NN
with  ||| S:1039 E:1044 ||| IN
TAB  ||| S:1044 E:1048 ||| NNP
length  ||| S:1048 E:1055 ||| NN
of  ||| S:1055 E:1058 ||| IN
5  ||| S:1058 E:1060 ||| CD
mm  ||| S:1060 E:1063 ||| NNS
or  ||| S:1063 E:1066 ||| CC
less ||| S:1066 E:1070 ||| JJR
,  ||| S:1070 E:1072 ||| ,
but  ||| S:1072 E:1076 ||| CC
increased  ||| S:1076 E:1086 ||| VBN
to  ||| S:1086 E:1089 ||| TO
71-79 ||| S:1089 E:1094 ||| CD
%  ||| S:1094 E:1096 ||| NN
with  ||| S:1096 E:1101 ||| IN
TAB  ||| S:1101 E:1105 ||| NNP
lengths  ||| S:1105 E:1113 ||| NNS
of  ||| S:1113 E:1116 ||| IN
6-20  ||| S:1116 E:1121 ||| CD
mm ||| S:1121 E:1123 ||| NN
,  ||| S:1123 E:1125 ||| ,
and  ||| S:1125 E:1129 ||| CC
to  ||| S:1129 E:1132 ||| TO
89 ||| S:1132 E:1134 ||| CD
%  ||| S:1134 E:1136 ||| NN
when  ||| S:1136 E:1141 ||| WRB
TAB  ||| S:1141 E:1145 ||| NNP
length  ||| S:1145 E:1152 ||| NN
was  ||| S:1152 E:1156 ||| VBD
longer  ||| S:1156 E:1163 ||| RBR
than  ||| S:1163 E:1168 ||| IN
20  ||| S:1168 E:1171 ||| CD
mm ||| S:1171 E:1173 ||| NNS
.  ||| S:1173 E:1175 ||| .
Only  ||| S:1175 E:1180 ||| RB
3 ||| S:1180 E:1181 ||| CD
%  ||| S:1181 E:1183 ||| NN
of  ||| S:1183 E:1186 ||| IN
positive  ||| S:1186 E:1195 ||| JJ
biopsies  ||| S:1195 E:1204 ||| NNS
were  ||| S:1204 E:1209 ||| VBD
5  ||| S:1209 E:1211 ||| CD
mm  ||| S:1211 E:1214 ||| NNS
or  ||| S:1214 E:1217 ||| CC
shorter ||| S:1217 E:1224 ||| JJR
,  ||| S:1224 E:1226 ||| ,
compared  ||| S:1226 E:1235 ||| VBN
to  ||| S:1235 E:1238 ||| TO
27 ||| S:1238 E:1240 ||| CD
%  ||| S:1240 E:1242 ||| NN
of  ||| S:1242 E:1245 ||| IN
TAB  ||| S:1245 E:1249 ||| NNP
in  ||| S:1249 E:1252 ||| IN
biopsy-negative  ||| S:1252 E:1268 ||| NNP
GCA  ||| S:1268 E:1272 ||| NNP
cases  ||| S:1272 E:1278 ||| NNS
( ||| S:1278 E:1279 ||| -LRB-
p  ||| S:1279 E:1280 ||| FW
< ||| S:1280 E:1281 ||| SYM
0.001 ||| S:1281 E:1286 ||| FW
) ||| S:1286 E:1287 ||| -RRB-
.  ||| S:1287 E:1289 ||| .
TAB  ||| S:1289 E:1293 ||| NN
with  ||| S:1293 E:1298 ||| IN
post-fixation  ||| S:1298 E:1312 ||| JJ
length  ||| S:1312 E:1319 ||| NN
shorter  ||| S:1319 E:1327 ||| JJR
than  ||| S:1327 E:1332 ||| IN
5  ||| S:1332 E:1334 ||| CD
mm  ||| S:1334 E:1337 ||| NN
carries  ||| S:1337 E:1345 ||| VBZ
an  ||| S:1345 E:1348 ||| DT
increased  ||| S:1348 E:1358 ||| JJ
biopsy-negative  ||| S:1358 E:1374 ||| JJ
rate  ||| S:1374 E:1379 ||| NN
therefore  ||| S:1379 E:1389 ||| RB
longer  ||| S:1389 E:1396 ||| RBR
TAB  ||| S:1396 E:1400 ||| JJ
length  ||| S:1400 E:1407 ||| NN
is  ||| S:1407 E:1410 ||| VBZ
required  ||| S:1410 E:1419 ||| VBN
for  ||| S:1419 E:1423 ||| IN
accurate  ||| S:1423 E:1432 ||| JJ
diagnosis ||| S:1432 E:1441 ||| NN
.  ||| S:1441 E:1443 ||| .
Increasing  ||| S:1443 E:1454 ||| VBG
post-fixation  ||| S:1454 E:1468 ||| JJ
TAB  ||| S:1468 E:1472 ||| NNP
length  ||| S:1472 E:1479 ||| NN
beyond  ||| S:1479 E:1486 ||| IN
20  ||| S:1486 E:1489 ||| CD
mm  ||| S:1489 E:1492 ||| NNS
may  ||| S:1492 E:1496 ||| MD
further  ||| S:1496 E:1504 ||| RB
increase  ||| S:1504 E:1513 ||| VB
the  ||| S:1513 E:1517 ||| DT
rate  ||| S:1517 E:1522 ||| NN
of  ||| S:1522 E:1525 ||| IN
positive  ||| S:1525 E:1534 ||| JJ
biopsies ||| S:1534 E:1542 ||| NNS
,  ||| S:1542 E:1544 ||| ,
although  ||| S:1544 E:1553 ||| IN
data  ||| S:1553 E:1558 ||| NNS
were  ||| S:1558 E:1563 ||| VBD
insufficient  ||| S:1563 E:1576 ||| JJ
in  ||| S:1576 E:1579 ||| IN
that  ||| S:1579 E:1584 ||| DT
regard ||| S:1584 E:1590 ||| NN
.  ||| S:1590 E:1592 ||| .
